Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance



Status:Completed
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:50 - 80
Updated:4/2/2016
Start Date:April 2011
End Date:April 2014
Contact:Migdalia Reid, RN, MPH
Email:migdalia.reid@einstein.yu.edu
Phone:718-405-8271

Use our guide to learn which trials are right for you!

The Effect of Resveratrol in Older Adults With Impaired Glucose Tolerance: a Double-Blind Crossover Study

Resveratrol is a substance found in many plants, including grapes and red wine, which is
widely used as a nutritional supplement. Studies in cells and lower animals show that
resveratrol has many potential benefits, including prolonging lifespan, preventing cancer
and heart disease and normalization of glucose metabolism. Although use of this agent shows
great promise in the treatment and/or prevention of diabetes, there have been no studies
reported to date in humans. As an initial step, this proposal is for a 6 week pilot study of
resveratrol treatment in older adults with impaired glucose tolerance (IGT) in order to
explore its effects on post-meal blood glucose metabolism. Preliminary studies will also be
conducted to explore how resveratrol works by studying cellular function (in muscle samples
obtained from study participants) and by testing resveratrol's effect on blood vessel
function.


Inclusion Criteria:

- impaired glucose tolerance

Exclusion Criteria:

- history of estrogen-dependent neoplasm

- use of certain drugs: high dose statins, warfarin, antiepileptics

- current treatment with anti-diabetes medications

- impaired liver or kidney function
We found this trial at
1
site
?
mi
from
Bronx, NY
Click here to add this to my saved trials